Qtpair 25 Tablet contains Quetiapine Fumarate I.P. 25mg, an atypical antipsychotic indicated for the treatment of schizophrenia, bipolar disorder, and other mood-related psychiatric conditions. It helps in managing psychotic symptoms, mood swings, and emotional instability.
Quetiapine works by modulating neurotransmitter activity, particularly dopamine and serotonin pathways in the brain, thereby reducing hallucinations, delusions, and mood episodes. Its low-dose formulation allows flexible titration according to patient needs.
For distributors and healthcare suppliers, Qtpair 25 Tablet is a high-demand psychiatric therapy product, commonly prescribed in psychiatric clinics, hospitals, and mental health care centers. The growing awareness of mental health disorders ensures steady demand across healthcare channels.
Adding Qtpair 25 Tablet to your antipsychotic and mood disorder therapy segment creates strong opportunities in pharmacies, hospitals, psychiatric clinics, export markets, and third-party manufacturing. Its efficacy, prescriber confidence, and broad patient applicability make it a valuable addition to pharmaceutical distribution portfolios.